| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0087 | 0.9 |